Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 7776105.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied changes in the atherogenic index (total cholesterol divided by high-density lipoprotein cholesterol) in 12 prepubertal boys with growth hormone (GH) deficiency during 9 months of GH treatment. High-density lipoprotein cholesterol level increased until 5 months without significant changes in total cholesterol level; thus GH therapy may be beneficial in reducing the atherogenic index in boys with GH deficiency.
Medical subject headings
- Arteriosclerosis
- Growth Hormone